[1] |
Ehrhardt JD Jr, Gulec SA. Birth of the beta-knife thyroidectomy:The radiance of saul hertz [J]. Am Surg, 2022:313482110604 63. DOI: 10.1177/00031348211060463.
|
[2] |
Sánchez Barrueco A, González Galán F, Alcalá Rueda I,et al. Incidence and risk factors for radioactive iodine-induced sialadenitis[J]. Acta Otolaryngol, 2020, 140(11):959-962. DOI: 10.1080/00016489.2020.1802507.
|
[3] |
Yasmin T, Adnan S, Younis MN,et al. Comparing high and low-dose radio-iodine therapy in thyroid remnant ablation among intermediate and low-risk papillary thyroid carcinoma patients-single centre experience[J]. Dose Response, 2021, 19(4):155 93258211062775. DOI: 10.1177/15593258211062775.
|
[4] |
Lei L, Velasco O, Nobay F. Iodide mumps:A case report of complicated radioactive iodine causing sialadenitis[J]. Am J Emerg Med, 2012, 30(3):512.e5-512.e6. DOI: 10.1016/j.ajem.2010.12.037.
|
[5] |
Nabaa B, Takahashi K, Sasaki T,et al. Assessment of salivary gland dysfunction after radioiodine therapy for thyroid carcinoma using non-contrast-enhanced CT:The significance of changes in volume and attenuation of the glands[J]. Am J Neuroradiol, 2012, 33(10):1964-1970. DOI: 10.3174/ajnr.A3063.
|
[6] |
Thorpe RK, Foggia MJ, Marcus KS,et al. Sialographic analysis of radioiodine-associated chronic sialadenitis[J]. Laryngoscope, 2021, 131(5):E1450-E1456. DOI: 10.1002/lary.29279.
|
[7] |
Lu L, Shan F, Li W,et al. Short-term side effects after radioiodine treatment in patients with differentiated thyroid cancer[J]. Biomed Res Int, 2016:4376720. DOI: 10.1155/2016/4376720.
|
[8] |
Oh JM, Kalimuthu S, Gangadaran P,et al. Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor(K905-0266)excavated by high-throughput NIS(sodium iodide symporter)enhancer screening platform using dual reporter gene system[J]. Oncotarget, 2018, 9(6):7075-7087. DOI: 10.18632/oncotarget.24159.
|
[9] |
Prendes BL, Orloff LA, Eisele DW. Therapeutic sialendoscopy for the management of radioiodine sialadenitis[J]. Arch Otolaryngol Head Neck Surg, 2012, 138(1):15-19. DOI: 10.1001/archoto.2011.215.
|
[10] |
Geres AE, Mereshian PS, Fernández S,et al. Sialadenitis after radioiodine therapy. Analysis of factors that influence the response to medical treatment[J]. Endocrinol Nutr, 2015, 62(10):493-498. DOI: 10.1016/j.endonu.2015.07.006.
|
[11] |
Wu CB, Xi H, Zhou Q,et al. Sialendoscopy-assisted treatment for radioiodine-induced sialadenitis[J]. J Oral Maxillofac Surg, 2015, 73(3):475-481. DOI: 10.1016/j.joms.2014.09.025.
|
[12] |
|
[13] |
Peng X, Wu Y, Brouwer U,et al. Cellular senescence contributes to radiation-induced hyposalivation by affecting the stem/progenitor cell niche[J]. Cell Death Dis, 2020, 11(10):854. DOI: 10.1038/s41419-020-03074-9.
|
[14] |
Gonzalez ME, Muttikkal TJE, Rehm PK. Sialadenitis following low dose I-131 diagnostic thyroid scan with Thyrogen ®(recombinant human thyroid stimulating hormone-thyrotropin alfa)[J]. J Radiol Case Rep, 2015, 9(6):44-49. DOI: 10.3941/jrcr.v9i6.2220.
|
[15] |
Katada R, Tanaka J, Takamatsu K,et al. Induction of salivary gland-like cells from epithelial tissues transdifferentiated from mouse embryonic fibroblasts[J]. Biochem Biophys Res Commun, 2022, 586:55-62. DOI: 10.1016/j.bbrc.2021.11.064.
|
[16] |
Feng X, Wu Z, Xu J,et al. Dietary nitrate supplementation prevents radiotherapy-induced xerostomia[J]. Elife, 2021, 10:e70710. DOI: 10.7554/eLife.70710.
|
[17] |
Klein Hesselink EN, Brouwers AH, de Jong JR,et al. Effects of radioiodine treatment on salivary gland function in patients with differentiated thyroid carcinoma:A prospective study[J]. J Nucl Med, 2016, 57(11):1685-1691. DOI: 10.2967/jnumed.115.169888.
|
[18] |
Mizrachi A, Cotrim AP, Katabi N,et al. Radiation-induced microvascular injury as a mechanism of salivary gland hypofunction and potential target for radioprotectors[J]. Radiat Res, 2016, 186(2):189-195. DOI: 10.1667/RR14431.1.
|
[19] |
Cotrim AP, Sowers A, Mitchell JB,et al. Prevention of irradiation-induced salivary hypofunction by microvessel protection in mouse salivary glands[J]. Mol Ther, 2007, 15(12):2101-2106. DOI: 10.1038/sj.mt.6300296.
|
[20] |
Xu J, Yan X, Gao R,et al. Effect of irradiation on microvascular endothelial cells of parotid glands in the miniature pig[J]. Int J Radiat Oncol Biol Phys, 2010, 78(3):897-903. DOI: 10.1016/j.ijrobp.2010.05.048.
|
[21] |
Liu Z, Dong L, Zheng Z,et al. Mechanism,prevention,and treatment of radiation-induced salivary gland injury related to oxidative stress[J]. Antioxidants(Basel), 2021, 10(11):1666. DOI: 10.3390/antiox10111666.
|
[22] |
Yamazaki H, Suzuki G, Aibe N,et al. Reirradiation for rare head and neck cancers:Orbit,auditory organ,and salivary glands[J]. Cureus, 2022, 14(2):e22727. DOI: 10.7759/cureus.22727.
|
[23] |
Moloney EC, Brunner M, Alexander AJ,et al. Quantifying fibrosis in head and neck cancer treatment:An overview[J]. Head Neck, 2015, 37(8):1225-1231. DOI: 10.1002/hed.23722.
|
[24] |
Lalkovicova M. Neuroprotective agents effective against radiation damage of central nervous system[J]. Neural Regen Res, 2022, 17(9):1885-1892. DOI: 10.4103/1673-5374.335137.
|
[25] |
An YS, Yoon JK, Lee SJ,et al. Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer[J]. Ann Nucl Med, 2013, 27(4):386-391. DOI: 10.1007/s12149-013-0697-5.
|
[26] |
Krčálová E, Horáček J, Gabalec F,et al. Scintigraphic evaluation of salivary gland function in thyroid cancer patients after radioiodine remnant ablation[J]. Eur J Oral Sci, 2020, 128(3):204-210. DOI: 10.1111/eos.12689.
|
[27] |
Singer MC, Marchal F, Angelos P,et al. Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer:American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology,ophthalmology,nuclear medicine and endocrinology[J]. Head Neck, 2020, 42(11):3446-3459. DOI: 10.1002/hed.26417.
|
[28] |
Son H, Lee SM, Yoon RG,et al. Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer[J]. Hell J Nucl Med, 2017, 20(1):62-70. DOI: 10.1967/s002449910508.
|
[29] |
Choi JS, Hong SB, Hyun IY,et al. Effects of salivary secretion stimulation on the treatment of chronic radioactive iodine-induced sialadenitis[J]. Thyroid, 2015, 25(7):839-845. DOI: 10.1089/thy.2014.0525.
|
[30] |
Gil-Montoya JA, Silvestre FJ, Barrios R,et al. Treatment of xerostomia and hyposalivation in the elderly:A systematic review[J]. Med Oral Patol Oral Cir Bucal, 2016, 21(3):e355-e366. DOI: 10.4317/medoral.20969.
|
[31] |
Karagozoglu KH, Vissink A, Forouzanfar T,et al. Sialendoscopy increases saliva secretion and reduces xerostomia up to 60 weeks in Sjögren′s syndrome patients:A randomized controlled study[J]. Rheumatology(Oxford), 2021, 60(3):1353-1363. DOI: 10.1093/rheumatology/keaa284.
|
[32] |
Jentzen W, Richter M, Nagarajah J,et al. Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy 124I PET/CT imaging[J]. EJNMMI Phys, 2014, 1(1):100. DOI: 10.1186/s40658-014-0100-1.
|
[33] |
Zhang T, Liu C, Ma S,et al. Protective effect and mechanism of action of rosmarinic acid on radiation-induced parotid gland injury in rats[J]. Dose Response, 2020, 18(1):15593258209 07782. DOI: 10.1177/1559325820907782.
|
[34] |
Li X, Zhao YN, Zhang LQ,et al. Differences between radioactive iodine-induced sialadenitis and chronic obstructive parotitis[J]. Int J Oral Maxillofac Surg, 2021:S0901-5027(21)00391-X. DOI: 10.1016/j.ijom.2021.11.003.
|
[35] |
Liu X, Cotrim A, Teos L,et al. Loss of TRPM2 function protects against irradiation-induced salivary gland dysfunction[J]. Nat Commun, 2013, 4:1515. DOI: 10.1038/ncomms2526.
|
[36] |
Timiri Shanmugam PS, Dayton RD, Palaniyandi S,et al. Recombinant AAV9-TLK1B administration ameliorates fractionated radiation-induced xerostomia[J]. Hum Gene Ther, 2013, 24(6):604-612. DOI: 10.1089/hum.2012.235.
|